Effectiveness of polyvalent influenza A vaccine during an influenza A-prime epidemic. 1954

G MEIKLEJOHN, and C H KEMPE, and W G THALMAN, and E H LENNETTE

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014612 Vaccines Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases. Vaccine

Related Publications

G MEIKLEJOHN, and C H KEMPE, and W G THALMAN, and E H LENNETTE
March 1958, American journal of hygiene,
G MEIKLEJOHN, and C H KEMPE, and W G THALMAN, and E H LENNETTE
June 1964, Obstetrics and gynecology,
G MEIKLEJOHN, and C H KEMPE, and W G THALMAN, and E H LENNETTE
February 1999, Journal of the American Geriatrics Society,
G MEIKLEJOHN, and C H KEMPE, and W G THALMAN, and E H LENNETTE
October 2000, Epidemiology and infection,
G MEIKLEJOHN, and C H KEMPE, and W G THALMAN, and E H LENNETTE
November 1958, The New England journal of medicine,
G MEIKLEJOHN, and C H KEMPE, and W G THALMAN, and E H LENNETTE
September 2023, Vaccine,
G MEIKLEJOHN, and C H KEMPE, and W G THALMAN, and E H LENNETTE
January 1968, American journal of epidemiology,
G MEIKLEJOHN, and C H KEMPE, and W G THALMAN, and E H LENNETTE
October 1957, Student medicine,
G MEIKLEJOHN, and C H KEMPE, and W G THALMAN, and E H LENNETTE
November 1967, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
G MEIKLEJOHN, and C H KEMPE, and W G THALMAN, and E H LENNETTE
September 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
Copied contents to your clipboard!